DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V.’s Post

The Global Cardiovascular Research Funders Forum (GCRFF) is proud to launch the International Research Challenge on Women’s Cardiovascular Health! This first of its kind network grant will support transformative research up to a value of US$ 10million over 5 years and aims to tackle critical knowledge gaps in women’s cardiovascular health. Through funding a network of the brightest minds and the best science, the challenge represents an opportunity for international, multi-disciplinary and multi-institution collaboration. Letters of intent (LOI) are due by January 15, 2025. To find out more and apply, visit https://bit.ly/3MwZlnu.

Coming soon... US$ 10 million International Research Challenge!     The Global Cardiovascular Research Funders Forum (GCRFF), a partnership of 12 research funding organizations across nine countries, is excited to share that the International Research Challenge on Women's Cardiovascular Health will be launching on September 25th this year. An international, multi-institutional, and multi-disciplinary research network grant of up to US$ 10 million over 5 years. A first-of-its-kind research funding opportunity to drive transformative research and build capacity at the international level.      This initiative aims to support transformative research and address urgent knowledge gaps in women’s cardiovascular health, that are of international relevance.  Learn more: https://bit.ly/3MwZlnu.

How can digital marketing data be collected systematically, comprehensively and regularly, with minimal resources and in a way that emulates different internet-user profiles? Researchers - Kathryn Backholer, Asim Bhatti, Navoda Liyanapathirana, Floretine Martino, Leo Saif, Bridget Kelly and Becky Freeman from IHT, IISRI — Institute for Intelligent Systems Research and Innovation, University of Sydney and University of Wollongong - propose to find out with the assistance of a Heart Foundation 2024 Research Grant that they were recently awarded. With the Vanguard Grant, it is proposed to develop proof-of-concept methods to hold industries accountable for the marketing of products that increase the risk of cardiovascular disease.

Three RCSI researchers have been awarded €3 million in funding by the Health Research Board (HRB) to support their career development as future leaders in health research. Their projects explore chronic obstructive pulmonary disease (COPD), the role of the lung microbiome in disease and kidney transplant rejection. Read more: https://lnkd.in/ecE3NZzR #RCSIdiscover Mark Murphy Imran Sulaiman

DEADLINE REMINDER! There is still time to apply to the GCRFF's International Research Challenge on Women's Cardiovascular Health. This first of its kind network grant will support transformative research up to a value of US$ 10million over 5 years and aims tackle critical knowledge gaps in women’s cardiovascular health. Through funding a network of the brightest minds and the best science, the challenge represents an opportunity for international, multi-disciplinary and multi-institution collaboration. 📅 Letters of Intent (LOI) are due by January 15, 2025. 📢 To find out more and apply, visit https://bit.ly/3AViUmN The GCRFF is a partnership of 12 major research funding organisations: American Heart Association, British Heart Foundation, Canadian Institutes of Health Research | Instituts de recherche en santé du Canada, DZHK Deutsches Zentrum für Herz-Kreislauf-Forschung e. V., Hartstichting, Heart Foundation, Heart Foundation NZ, Heart & Stroke, Hjerteforeningen, LEDUCQ FOUNDATION FOR CARDIOVASCULAR RESEARCH, National Heart, Lung, and Blood Institute, Schweizerische Herzstiftung

This study investigates the association between vitiligo and autoimmune co-morbidities in a US-based cohort using the All of Us database. By analyzing electronic health record data, researchers identified vitiligo patients using specific SNOMED codes. The findings contribute to understanding the link between vitiligo and autoimmune diseases, emphasizing the importance of diverse participant representation in biomedical research. #vitiligo #AutoimmuneDiseases #ResearchAnalysis #AllOfUsProgram #HealthDataStudy Read more here: https://lnkd.in/dQCTg8Xp

🆕 New paper out 👇 I am happy and honored to be part of this paper, which is related to the ISCoS Physical Activity Special Interest Group. The paper was led by postdoc Matteo Ponzano (first author) and professor Kathleen Martin Ginis (last author), with contributions from several co-authors as part of an international consensus process. Adopting these recommendations will increase the quality of the research and the overall certainty of the evidence regarding the effects of exercise on health outcomes in this population. https://lnkd.in/d_SN5K-H #UCL #SDU

🚀 I’m excited to announce the publication of two of my conference proceedings that expand on critical topics in infrastructure and healthcare 🎉 1. Infrastructure Resilience: Bibliometric and Network Analysis Focus: Building resilient infrastructures Method: Bibliometric analysis of thousands of articles Insights: Key resilience principles like flexibility and adaptability for policymakers and industry leaders 🔗 DOI: https://lnkd.in/gWqa2QXh 2. Cardiovascular Risk Prediction Through Stacking Classifier Focus: Early detection of cardiovascular disease (CVD) Approach: Machine learning with stacked boosting techniques Impact: Supports hospitals in preventive care and resource management 🔗 DOI: https://lnkd.in/gXnvSb2G A big thank you to my Supervisor Dr. Niamat Ullah Ibne Hossain and my co-authors Fazla Rabbi and Dr. Alexandr M. Sokolov, Ph.D., M.B.A. for their invaluable support. #Research #Publication #MachineLearning #Infrastructure

Christopher G. Low, MD, and team: Maqdooda Merchant, MSc, MA, Yun-Yi Hung, PhD, Yu Hsin Liu, MD, Joseph Vu, MD, and Seema Pursnani, MD, MPH, collaborated with the Santa Clara Internal Medicine Residency Program, Kaiser Permanente Northern California Residency and Fellowship Programs, and Kaiser Permanente Division of Research to answer this important public health question.  Article: https://lnkd.in/gYBRKRAw Citation: Low CG, Merchant M, Hung YY, Liu YH, Vu J, Pursnani S. Assessing Glycosylated Hemoglobin Thresholds for Development of Cardiovascular Disease by Racial and Ethnic Groups. J Am Heart Assoc. 2024 May 21;13(10):e033559. doi: 10.1161/JAHA.123.033559. Epub 2024 May 18. PMID: 38761085; PMCID: PMC11179793.

🌟 On this World Amyloidosis Day, we are proud to highlight Jacquie Baker, recipient of the CCS-Pfizer ATTR-CM 2023 Research Fellowship Award. 🔍 Jacquie is a postdoctoral associate at the Cumming School of Medicine in Calgary where she is studying the impact of autonomic health on #amyloidosis patients. When the autonomic nervous system is impaired, it can cause symptoms like lightheadedness, dizziness, difficulty regulating body temperature, and problems with blood pressure control. These challenges can impact daily activities, independence, and overall quality of life for patients. 💡 We are proud to support researchers like Jacquie and partner with organizations such as the Canadian Cardiovascular Society. Through our collective efforts, we aim to enhance understanding, improve patient outcomes, and make a positive impact on the lives of amyloidosis patients and their loved ones! To learn more about Jacquie’s project visit: https://lnkd.in/evwNuHDt 🙌 💙 #WorldAmyloidosisDay #ResearchMatters #ImprovingPatientCare